Company:  LIGAND PHARMACEUTICALS IN ... (LGND)
Form Type:  4
Filing Date:  12/20/2022 
CIK:  0000886163 
Address:  3911 SORRENTO VALLEY BLVD
SUITE 110
 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  858-550-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$73.56  
Change: 
2.16 (3.03%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.26B
Trade LGND now with 

© 2023  
Description of Business
Our business is focused on acquiring or funding programs and technologies that pharmaceutical companies use to discover and develop medicines. Our business model provides a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. The biotechnology industry is characterized by a binary clinical risk, in that, either a drug candidate is successfully developed and receives regulatory marketing approval, or the drug candidate fails in clinical trials. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner while mitigating the binary clinical risk associated with developing a single program. Our business model is focused on funding mid to late-stage drug development in return for economic rights and out-licensing our technology platforms to help partners discover and develop medicines.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES


EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.